insights_auto
Prečo akcie ALMKT klesli 2,90%?
Preskúmať podrobnejšiechevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,12 €
arrow_downward
-2,90%(-0,0036) 1 d.
5. 10., 14:41:16 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre ALMKT…
Otvoriť
0,13 €
Vysoká
0,13 €
Nízka
0,12 €
Trh. kap.
24,37 mil.
Priem. obj.
440,14 tis.
Objem
472,52 tis.
Pomer cena/zárobky
0,99
Max. za 52 týž.
0,23 €
Min. za 52 týž.
0,07 €
Výnosy na akciu
0,12 €
Akcie v obehu
195,26 mil.
Počet zamestnancov
59
Otvoriť
0,13 €
Vysoká
0,13 €
Nízka
0,12 €
Trh. kap.
24,37 mil.
Priem. obj.
440,14 tis.
Objem
472,52 tis.
Pomer cena/zárobky
0,99
Max. za 52 týž.
0,23 €
Min. za 52 týž.
0,07 €
Výnosy na akciu
0,12 €
Akcie v obehu
195,26 mil.
Počet zamestnancov
59
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
www.marketscreener.com
·
pred 20 minútami
U.S. Based Rare Earth Company Winner Water to Join SPD and Mobix Labs (Nasdaq: MOBX) National Security Matters Initiative
Business Wire
·
pred 1 hodinou
Powerus (Nasdaq: PUSA) Awarded $82 Million Order for Counter-Unmanned Aerial Systems
Simply Wall Street
·
pred 32 minútami
Should Engine Ignition Test Require Action From Kratos (KTOS) Investors?
MarketWatch
·
pred 1 hodinou
An AI ‘reality check’ may take the S&P 500 to 5,000. Here are the trades to make, this strategist says.
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Informácie o subjekte Mauna Kea Technologies SA
Generálny riaditeľSacha Loiseau
Zamestnanci59
Dátum založenia2000
Hlavné sídlo-
Odvetvie-